Impact of rivaroxaban on point-of-care assays.
Fontana P, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Schmid P, Stricker H, Studt JD, Tsakiris DA, Wuillemin WA, Nagler M.
Fontana P, et al. Among authors: tsakiris da.
Thromb Res. 2017 May;153:65-70. doi: 10.1016/j.thromres.2017.03.019. Epub 2017 Mar 21.
Thromb Res. 2017.
PMID: 28343143
Clinical Trial.